—
—
—
—

Events processed in past 24 hours


PHOTOMEDEX INC

PHOTOMEDEX INC files SEC Filing Form 3

Jason Zucchetto December 22, 2011 PHMD 

MONTGOMERYVILLE, PA — Katsumi Oneda's title was listed as "Director" at Photomedex Inc within the filing.

If we look over the past 12 months, Katsumi Oneda has sold no shares of Photomedex Inc stock. Over the same time period, Katsumi Oneda has purchased no shares of Photomedex Inc stock.

Let's take a quick, high-level look at insider trading at Photomedex Inc over the past 12 months. No shares of Photomedex Inc stock were sold by company insiders. Over the same time 12 month time period, 8,000 shares of Photomedex Inc, for a total value of $116,773 were purchased by company insiders.

In addition to Katsumi Oneda's role with Photomedex Inc, Katsumi Oneda has affiliations with 1 other company. Katsumi Oneda's affiliations include Vision Sciences Inc /de/, Photomedex Inc .

To view the complete SEC Filing: Photomedex Inc 3 (Insider Trading (Form 3)) SEC Filing


View the complete filing
Form 3 Filing
Contact the reporter
Jason Zucchetto  jason@marketbrief.com





Markets
Marketbrief Pro
  • Learn About Pro
  • Subscribe
Account
About



Twitter Accounts: Latest IPO Filings and Amendments @IPOFilings | Latest Form D Filings @StartupsFormD

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither MarketBrief, Inc. nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the MarketBrief site, you agree not to redistribute the information found therein.

MarketBrief has no affiliation with the U.S. Securities and Exchange Commission (SEC).

MarketBrief is powered by Linode.

Information on MarketBrief is deemed reliable but not guaranteed. A very small percentage of SEC Filings contain errors by the filer. The systems at MarketBrief catch the majority of these filer errors, please report any suspicious statistics or filings to info@marketbrief.com.